You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 24, June 28, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Research Advances Target Epilepsy

Charles Marwick

JAMA. 2000;283:3187-3188.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Bethesda, Md—Recent advances in technology, pharmacology, and genetics that will improve the treatment of seizures and perhaps even prevent them. New imaging tools have emerged, effective drugs may be developed that can target specific areas of the brain, and data from the Human Genome Project are providing information about the genetics of the disease.

"There's no question that epilepsy research is ready for a dramatic expansion, both in the kinds of research going on and in the quality of that research. It will open the way to the diagnosis and treatment of the underlying condition before the advent of seizures," said Gerald D. Fischbach, MD. He was speaking at a White House conference entitled "Curing Epilepsy: Focus on the Future," which was held this spring at the National Institutes of Health.

Fischbach, who is director of the National Institute of Neurological Disorders and Stroke, announced the formation . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.